BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25639889)

  • 1. Propranolol and prednisolone combination for the treatment of segmental haemangioma in PHACES syndrome.
    Gnarra M; Solman L; Harper J; Batul Syed S
    Br J Dermatol; 2015 Jul; 173(1):242-6. PubMed ID: 25639889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facial segmental haemangioma with PHACE Syndrome successfully treated with oral propranolol.
    Lim TH; Yap E; Norhatizah BS
    Med J Malaysia; 2019 Oct; 74(5):447-449. PubMed ID: 31649228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol for the treatment of infantile haemangiomas: our experience with 44 patients.
    Lynch M; Lenane P; O'Donnell BF
    Clin Exp Dermatol; 2014 Mar; 39(2):142-5. PubMed ID: 24289272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHACES Syndrome and Associated Anomalies: Risk Associated With Small and Large Facial Hemangiomas.
    Proisy M; Powell J; McCuaig C; Jalbout RE; Lapierre C; Dubois J
    AJR Am J Roentgenol; 2021 Aug; 217(2):507-514. PubMed ID: 34036811
    [No Abstract]   [Full Text] [Related]  

  • 5. Ocular and systemic manifestations of PHACES (Posterior fossa malformations, Hemangiomas, Arterial anomalies, Cardiac defects and coarctation of the Aorta, Eye abnormalities, and Sternal abnormalities or ventral developmental defects) syndrome.
    Kronenberg A; Blei F; Ceisler E; Steele M; Furlan L; Kodsi S
    J AAPOS; 2005 Apr; 9(2):169-73. PubMed ID: 15838446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infantile haemangioma and intracranial vascular malformation].
    Ommen LB; Helgestad J; Gammelgaard L
    Ugeskr Laeger; 2009 Sep; 171(38):2745-7. PubMed ID: 19758499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative administration of propranolol reduced the surgical risks of PHACES syndrome in a 14-month-old girl.
    Rokugo Y; Ota C; Kimura M; Sasahara Y
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 31036736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma.
    Truong MT; Chang KW; Berk DR; Heerema-McKenney A; Bruckner AL
    J Pediatr; 2010 Feb; 156(2):335-8. PubMed ID: 20105647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infantile hemangioma associated with PHACES syndrome showing a dramatic response to oral propranolol.
    Singh BA; Harsha YS; Reddy BS
    Indian J Dermatol Venereol Leprol; 2015; 81(5):549. PubMed ID: 26087086
    [No Abstract]   [Full Text] [Related]  

  • 10. PHACES syndrome: otolaryngic considerations in recognition and management.
    Rudnick EF; Chen EY; Manning SC; Perkins JA
    Int J Pediatr Otorhinolaryngol; 2009 Feb; 73(2):281-8. PubMed ID: 19081148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four new cases of PHACES syndrome: variable phenotypic expression and endocrine features.
    Mussa A; Baldassarre G; Rosaia De Santis L; Gastaldi R; Corrias A; Silengo MC
    Acta Paediatr; 2008 Dec; 97(12):1729-33. PubMed ID: 18801022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small facial haemangioma and supraumbilical raphe--a forme fruste of PHACES syndrome?
    Chan YC; Eichenfield LF; Malchiodi J; Friedlander SF
    Br J Dermatol; 2005 Nov; 153(5):1053-7. PubMed ID: 16225625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHACES: a neurocutaneous syndrome with anomalies of the aorta and supraaortic vessels.
    Wendelin G; Kitzmüller E; Salzer-Muhar U
    Cardiol Young; 2004 Apr; 14(2):206-9. PubMed ID: 15691414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemangioma and propranolol.
    Engberg Damsgaard T; Vandborg Bjerre J
    J Plast Surg Hand Surg; 2014 Feb; 48(1):86-8. PubMed ID: 23837510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of propranolol for treatment of hemangiomas in PHACE syndrome.
    Solomon T; Ninnis J; Deming D; Merritt TA; Hopper A
    J Perinatol; 2011 Nov; 31(11):739-41. PubMed ID: 22037156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol-responsive cranial nerve palsies in a patient with PHACES syndrome.
    El Rassi E; MacArthur CJ
    Int J Pediatr Otorhinolaryngol; 2015 Oct; 79(10):1778-81. PubMed ID: 26282503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHACES Syndrome with Intestinal Hemangiomatosis.
    Vrkić Boban I; Lozić B; Stričević L; Čulo Čagalj I; Skelin Glavaš A; Krželj V
    Acta Dermatovenerol Croat; 2019 Dec; 27(4):265-269. PubMed ID: 31969240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants.
    Metry D; Frieden IJ; Hess C; Siegel D; Maheshwari M; Baselga E; Chamlin S; Garzon M; Mancini AJ; Powell J; Drolet BA
    Pediatr Dermatol; 2013; 30(1):71-89. PubMed ID: 22994362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique case of PHACES syndrome confirming the assumption that PHACES syndrome and the sternal malformation-vascular dysplasia association are part of the same spectrum of malformations.
    Vermeer S; van Oostrom CG; Boetes C; Verrips A; Knoers NVAM
    Clin Dysmorphol; 2005 Oct; 14(4):203-206. PubMed ID: 16155423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines.
    Solman L; Glover M; Beattie PE; Buckley H; Clark S; Gach JE; Giardini A; Helbling I; Hewitt RJ; Laguda B; Langan SM; Martinez AE; Murphy R; Proudfoot L; Ravenscroft J; Shahidullah H; Shaw L; Syed SB; Wells L; Flohr C
    Br J Dermatol; 2018 Sep; 179(3):582-589. PubMed ID: 29774538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.